(Q33209400)

English

High-dose vitamin E supplementation does not diminish ribavirin-associated haemolysis in hepatitis C treatment with combination standard alpha-interferon and ribavirin

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

High-dose vitamin E supplementation does not diminish ribavirin-associated haemolysis in hepatitis C treatment with combination standard alpha-interferon and ribavirin (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

1 reference

based on heuristic

inferred from title

author name string

K Saeian

1

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

J S Bajaj

2

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

J Franco

3

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

J F Knox

4

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

J Daniel

5

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

C Peine

6

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

D McKee

7

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

R R Varma

8

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

S Ho

9

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Midwest Hepatitis Study Group

10

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

language of work or name

0 references

publication date

1 November 2004

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

1189-1193

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

Factors influencing ribavirin-induced hemolysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02260.X

21 January 2018

Vitamin E and its role in the prevention of atherosclerosis and carcinogenesis: a review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02260.X

21 January 2018

Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02260.X

21 January 2018

Vitamin E for chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02260.X

21 January 2018

Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02260.X

21 January 2018

Once-weekly epoetin alfa improves anemia and facilitates maintenance of ribavirin dosing in hepatitis C virus-infected patients receiving ribavirin plus interferon alfa

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.02260.X

21 January 2018

Identifiers

10.1111/J.1365-2036.2004.02260.X

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33209400&oldid=1537284259"